Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms

Pharmiweb.com RSS Feed Pharmiweb.com RSS Feeds

Advertising

Press Release

Medtronic Releases Fiscal Year 2017 Integrated Performance Report

Medtronic plc
Posted on: 02 Nov 17

Report Highlights Company's Global Financial, Social, and Environmental Impact

DUBLIN - November 2, 2017 - Medtronic plc (NYSE:MDT) announces the release of its fiscal year 2017 Integrated Performance Report. The report highlights the combined financial, social, and environmental impact of Medtronic.

The FY2017 Integrated Performance Report details the company's commitment to addressing business and industry challenges. Based on the Global Reporting Initiative (GRI) G4 Guidelines, it's organized around the Medtronic sustainability material issues:

  • Access to Care
  • Product Quality
  • Product Stewardship
  • Responsible Supply Management
  • Ethics in Sales and Marketing

A tenet of the Medtronic Mission - to maintain good citizenship as a company - drives a sense of purpose and responsibility to not only deliver the highest quality products, therapies, and services to patients, but to also support healthy communities in the areas in which it operates.

In fiscal year 2017, Medtronic:

  • Invested $2.2 billion in research and development, representing 7.4 percent of net sales
  • Launched Medtronic Labs, a new initiative designed to deliver financially sustainable businesses that expand access and reduce health inequality in emerging markets
  • Invested $139.7 million in capacity building and training for medical professionals and $22.6 million in patient education
  • Donated $101.8 million to charitable causes through corporate cash contributions, giving through the Medtronic Foundation, product donations, and employee volunteering
  • Invested more than $76 million in employee training and development programs
  • Reached early achievements of four of its 2020 Environmental Performance Goals, including reductions in energy, emissions, waste, and water

The report and Global Reporting Initiative (GRI) Supplement is available for download at www.medtronic.com/SustainabilityReport .

About Medtronic
Medtronic plc ( www.medtronic.com ), headquartered in Dublin, Ireland, is among the world's largest medical technology, services and solutions companies - alleviating pain, restoring health and extending life for millions of people around the world. Medtronic employs more than 84,000 people worldwide, serving physicians, hospitals and patients in approximately 160 countries. The company is focused on collaborating with stakeholders around the world to take healthcare Further, Together.

Any forward-looking statements in this release or the 2017 Integrated Performance Report are subject to risks and uncertainties such as those described in Medtronic's periodic reports on file with the Securities and Exchange Commission. Actual results may differ materially from anticipated results.

-end- 

 

Contacts:
Fernando Vivanco
Public Relations
+1-763-505-3780

Ryan Weispfenning
Investor Relations
+1-763-505-4626



This announcement is distributed by Nasdaq Corporate Solutions on behalf of Nasdaq Corporate Solutions clients.

The issuer of this announcement warrants that they are solely responsible for the content, accuracy and originality of the information contained therein.

Source: Medtronic plc via GlobeNewswire
HUG#2146932
GlobeNewswire
globenewswire.com

Last updated on: 03/11/2017

Advertising
Site Map | Privacy & Security | Cookies | Terms and Conditions

PharmiWeb.com is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on PharmiWeb.com is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.